tiprankstipranks
Nuo Therapeutics (AURX)
OTHER OTC:AURX
US Market
AURX
Nuo Therapeutics
RESEARCH TOOLSreports
Want to see AURX full AI Analyst Report?

Nuo Therapeutics (AURX) Ratios

12 Followers

Nuo Therapeutics Ratios

AURX's free cash flow for Q2 2026 was $0.66. For the 2026 fiscal year, AURX's free cash flow was decreased by $ and operating cash flow was $-0.09. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.28 1.06 1.45 2.32 4.39
Quick Ratio
 1.11 0.89 1.19 2.01 3.99
Cash Ratio
 0.29 0.42 0.49 1.38 3.42
Solvency Ratio
 -0.44 -0.84 -3.30 -3.66 -3.45
Operating Cash Flow Ratio
 -1.38 -0.66 -3.86 -4.70 -6.17
Short-Term Operating Cash Flow Coverage
 -35.78 0.00 0.00 0.00 -46.65
Net Current Asset Value
$ -2.17M$ -1.42M$ 165.75K$ 724.71K$ 1.78M
Leverage Ratios
Debt-to-Assets Ratio
 0.57 0.32 0.14 0.14 0.11
Debt-to-Equity Ratio
 -0.97 -0.62 0.32 0.25 0.15
Debt-to-Capital Ratio
 -38.39 -1.66 0.24 0.20 0.13
Long-Term Debt-to-Capital Ratio
 -14.50 -1.10 0.00 0.00 0.00
Financial Leverage Ratio
 -1.71 -1.93 2.32 1.81 1.39
Debt Service Coverage Ratio
 -4.45 -2.93K 0.00 -968.70 -37.96
Interest Coverage Ratio
 -5.96 -3.13K 0.00 -1.00K -1.58K
Debt to Market Cap
 0.02 <0.01 0.00 0.00 <0.01
Interest Debt Per Share
 0.04 0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 -0.67 -0.02 0.05 0.22 0.55
Profitability Margins
Gross Profit Margin
64.11%66.94%77.82%79.28%82.88%
EBIT Margin
-33.27%-75.95%-180.04%-520.65%-2823.73%
EBITDA Margin
-29.99%-71.21%-172.99%-503.35%-2757.73%
Operating Profit Margin
-33.32%-75.95%-180.04%-520.65%-2958.21%
Pretax Profit Margin
-38.70%-75.82%-170.21%-521.17%-2825.60%
Net Profit Margin
-38.70%-75.82%-170.21%-521.17%-2695.14%
Continuous Operations Profit Margin
-38.70%-75.82%-170.21%-521.17%-2825.60%
Net Income Per EBT
100.00%100.00%100.00%100.00%95.38%
EBT Per EBIT
116.16%99.82%94.54%100.10%95.52%
Return on Assets (ROA)
-76.63%-136.11%-195.35%-168.88%-99.28%
Return on Equity (ROE)
187.41%262.63%-452.34%-305.20%-138.06%
Return on Capital Employed (ROCE)
-161.57%-466.58%-402.23%-263.29%-135.70%
Return on Invested Capital (ROIC)
-153.00%-408.69%-362.56%-244.70%-127.43%
Return on Tangible Assets
-76.63%-136.11%-195.35%-168.88%-99.28%
Earnings Yield
-3.33%-2.70%-3.65%-13.70%-5.04%
Efficiency Ratios
Receivables Turnover
 4.45 5.90 5.50 2.43 1.22
Payables Turnover
 3.31 2.51 1.38 0.32 0.05
Inventory Turnover
 6.93 5.13 2.01 0.60 0.08
Fixed Asset Turnover
 8.22 7.11 3.92 1.94 0.27
Asset Turnover
 1.98 1.80 1.15 0.32 0.04
Working Capital Turnover Ratio
 17.61 19.68 2.37 0.42 0.15
Cash Conversion Cycle
 24.54 -12.20 -16.50 -384.94 -2.70K
Days of Sales Outstanding
 81.95 61.87 66.36 150.37 300.19
Days of Inventory Outstanding
 52.70 71.22 181.32 606.70 4.56K
Days of Payables Outstanding
 110.11 145.29 264.18 1.14K 7.55K
Operating Cycle
 134.66 133.09 247.68 757.07 4.86K
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.04 -0.02 -0.05 -0.08 -0.09
Free Cash Flow Per Share
 -0.05 -0.02 -0.05 -0.08 -0.09
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.14 1.32 1.07 1.00 1.02
Dividend Paid and CapEx Coverage Ratio
 -7.24 -3.15 -14.40 -437.30 -61.78
Capital Expenditure Coverage Ratio
 -7.24 -3.15 -14.40 -437.30 -61.78
Operating Cash Flow Coverage Ratio
 -1.44 -1.45 -13.59 -12.39 -11.06
Operating Cash Flow to Sales Ratio
 -0.41 -0.26 -1.63 -5.21 -33.02
Free Cash Flow Yield
-4.04%-1.22%-3.75%-13.72%-6.28%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -29.90 -37.10 -27.37 -7.30 -19.83
Price-to-Sales (P/S) Ratio
 11.64 28.13 46.58 38.03 534.54
Price-to-Book (P/B) Ratio
 -39.41 -97.44 123.79 22.27 27.38
Price-to-Free Cash Flow (P/FCF) Ratio
 -24.73 -81.78 -26.65 -7.29 -15.93
Price-to-Operating Cash Flow Ratio
 -28.15 -107.76 -28.50 -7.31 -16.19
Price-to-Earnings Growth (PEG) Ratio
 -1.30 -10.00 0.85 27.58 >-0.01
Price-to-Fair Value
 -39.41 -97.44 123.79 22.27 27.38
Enterprise Value Multiple
 -39.47 -39.52 -26.88 -7.34 -18.83
Enterprise Value
 61.56M 93.25M 63.47M 22.47M 58.29M
EV to EBITDA
 -39.47 -39.52 -26.88 -7.34 -18.83
EV to Sales
 11.84 28.14 46.50 36.92 519.25
EV to Free Cash Flow
 -25.16 -81.82 -26.60 -7.08 -15.48
EV to Operating Cash Flow
 -28.63 -107.81 -28.44 -7.09 -15.73
Tangible Book Value Per Share
 -0.03 -0.02 0.01 0.02 0.05
Shareholders’ Equity Per Share
 -0.03 -0.02 0.01 0.02 0.05
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.11 0.07 0.03 0.01 <0.01
Net Income Per Share
 -0.04 -0.05 -0.05 -0.08 -0.08
Tax Burden
 1.00 1.00 1.00 1.00 0.95
Interest Burden
 1.16 1.00 0.95 1.00 1.00
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.97 1.43 2.58 0.00 0.00
Stock-Based Compensation to Revenue
 0.02 0.03 0.04 0.04 0.08
Income Quality
 1.07 0.34 0.96 1.00 1.17
Currency in USD